Swedish Orphan Biovitrum AB | Cash Flow
Fiscal year is January-December. All values SEK Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
93
268
65
802
1,149
2,418
Depreciation, Depletion & Amortization
305
313
320
441
474
485
Other Funds
-
183
14
764
366
458
Funds from Operations
165
299
411
642
1,431
2,341
Changes in Working Capital
20
66
96
300
98
250
Net Operating Cash Flow
185
234
507
343
1,333
2,090
Capital Expenditures
410
183
146
164
139
Sale of Fixed Assets & Businesses
-
-
2
7
1
Purchase/Sale of Investments
2
-
-
-
1
Net Investing Cash Flow
405
184
143
158
139
Issuance/Reduction of Debt, Net
200
20
-
331
500
Net Financing Cash Flow
207
20
22
308
500
Net Change in Cash
12
74
385
118
693
Free Cash Flow
159
211
480
297
1,285
Deferred Taxes & Investment Tax Credit
46
71
12
164
175
103
Change in Capital Stock
7
-
22
24
-
Exchange Rate Effect
1
4
2
5
1
About Swedish Orphan Biovitrum AB
View Profile
